A randomized, double-blind, placebo-controlled trial of a traditional herbal formula, Yukmijihwang-tang in elderly subjects with xerostomia

被引:11
|
作者
Han, Gajin [1 ,2 ]
Ko, Seok-Jae [2 ]
Kim, Juyeon [2 ]
Oh, Ja-Young [2 ]
Park, Jae-Woo [2 ]
Kim, Jinsung [2 ]
机构
[1] Kyung Hee Univ, Korean Med Hosp, Korean Med Clin Trial Ctr, 23 Kyungheedae Ro, Seoul, South Korea
[2] Kyung Hee Univ, Grad Sch, Dept Korean Gastroenterol, 26 Kyungheedae Ro, Seoul 130701, South Korea
关键词
Yukmijihwang-tang; Herbal medicine; Xerostomia; Salivary flow; Yin deficiency; Oral moisture; IMMUNOGLOBULIN-A; ORAL MUCOSAL; DRY MOUTH; ADULTS; SALIVA;
D O I
10.1016/j.jep.2016.02.014
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Yukmijihwang-tang (YMJ) is a typical herbal formula to treat Yin-deficiency (YD) syndrome by enriching the fluid-humor of the body. YMJ has been used to treat dry mouth symptoms for hundreds of years in traditional East Asian medicine. Xerostomia, a subjective oral dryness, is common in the elderly and results in impaired quality of life. Many conventional treatments for xerostomia provide only temporary symptom relief, and have side effects. The aim of this study is to investigate the efficacy and safety of YMJ for the treatment of xerostomia in the elderly. Methods: This study was designed as a randomized, placebo-controlled, double-blinded, two center trial. Ninety-six subjects aged 60-80 years who had experienced xerostomia for at least 3 months and presented with score > 40 on the visual analog scale (VAS) for subjective oral dryness were recruited and randomly allocated to YMJ and placebo groups. YMJ or placebo was administered to each group for 8 weeks (3 g of YMJ or placebo, three times per day). The primary outcome was change of VAS for xerostomia from 0 to 8 weeks. Results: VAS for xerostomia was decreased by 22.04 +/- 22.76 in the YMJ group and 23.58 +/- 23.04 in the placebo group. YMJ had no effect on xerostomia. However, participants with BMIs lower than 29.37 kg/m(2) showed improvement of xerostomia after 8 weeks of treatment with YMJ compared to placebo. In addition, YMJ improved oral moisture, which is associated with subjective oral dryness in the YMJ group, and the relationship between VAS for xerostomia and YD was significant. Conclusion: A trend was observed in which YMJ improved oral moisture status and subjective oral dryness in elderly subjects with lower BMI and greater tendency toward YD. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 50 条
  • [41] A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
    Turner, R. Scott
    Thomas, Ronald G.
    Craft, Suzanne
    van Dyck, Christopher H.
    Mintzer, Jacobo
    Reynolds, Brigid A.
    Brewer, James B.
    Rissman, Robert A.
    Raman, Rema
    Aisen, Paul S.
    NEUROLOGY, 2015, 85 (16) : 1383 - 1391
  • [42] Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
    Levin, B
    Thompson, JLP
    Levy, G
    Mitsumoto, H
    Kaufmann, P
    NEUROLOGY, 2006, 66 (11) : 1786 - 1786
  • [43] Lansoprazole in Globus Pharyngeus: Double-Blind, Randomized, Placebo-Controlled Trial
    Dumper, Jaymi
    Mechor, Brad
    Chau, Jason
    Allegretto, Michael
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 37 (05): : 657 - 663
  • [44] Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial
    Khan, AA
    Bilezikian, JP
    Kung, AWC
    Ahmed, MM
    Dubois, SJ
    Ho, AYY
    Schussheim, D
    Rubin, MR
    Shaikh, AM
    Silverberg, SJ
    Standish, TI
    Syed, Z
    Syed, ZA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07): : 3319 - 3325
  • [45] DEXAMETHASONE FOR THE TREATMENT OF DEPRESSION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    ARANA, GW
    SANTOS, AB
    LARAIA, MT
    MCLEODBRYANT, S
    BEALE, MD
    RAMES, LJ
    ROBERTS, JM
    DIAS, JK
    MOLLOY, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (02): : 265 - 267
  • [46] Fluoxetine for depression in diabetes - A randomized double-blind placebo-controlled trial
    Lustman, PJ
    Freedland, KE
    Griffith, LS
    Clouse, RE
    DIABETES CARE, 2000, 23 (05) : 618 - 623
  • [47] Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial
    Bruera, Eduardo
    El Osta, Badi
    Valero, Vicente
    Driver, Larry C.
    Pei, Be-Lian
    Shen, Loren
    Poulter, Valerie A.
    Palmer, J. Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3475 - 3481
  • [48] Creatine Supplementation in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alves, Christiano R. R.
    Santiago, Bianca M.
    Lima, Fernanda R.
    Otaduy, Maria C. G.
    Calich, Ana Luisa
    Tritto, Aline C. C.
    de Sa Pinto, Ana Lucia
    Roschel, Hamilton
    Leite, Claudia C.
    Benatti, Fabiana B.
    Bonfa, Eloisa
    Gualano, Bruno
    ARTHRITIS CARE & RESEARCH, 2013, 65 (09) : 1449 - 1459
  • [49] Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy
    Kissel, JT
    McDermott, MP
    Mendell, JR
    King, WM
    Pandya, S
    Griggs, RC
    Tawil, R
    Cos, L
    Langsam, A
    Martens, B
    Brower, C
    Herr, BE
    Figlewicz, D
    Forrester, J
    Downing, K
    Holloway, RG
    Hubble, J
    Kolassa, J
    NEUROLOGY, 2001, 57 (08) : 1434 - 1440
  • [50] A Double-Blind, Placebo-Controlled, Randomized Trial of Montelukast for Acute Bronchiolitis
    Amirav, Israel
    Luder, Anthony S.
    Kruger, Natalie
    Borovitch, Yael
    Babai, Ilan
    Miron, Dan
    Zuker, Miriam
    Tal, Gay
    Mandelberg, Avigdor
    PEDIATRICS, 2008, 122 (06) : E1249 - E1255